Coronary angioplasty with or without stent implantation for acute myocardial infarction

New England Journal of Medicine

Volumn 341, Issue 26, 1999, Pages 1949-1956

  Grines, Cindy L ^a   Cox, David A ^b   Stone, Gregg W ^c   Garcia, Eulogio ^d   Mattos, Luiz A ^e   Giambartolomei, Alessandro ^f   Brodie, Bruce R ^g   Madonna, Olivier ^h   Eijgelshoven, Marcel ⁱ   Lansky, Alexandra J ^c   O'Neill, William W ^a   Morice, Marie Claude ^j  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

^b Mid Carolina Cardiology   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^f St Joseph's Hospital   (United States)

^g LeBauer Health Care   (United States)

^h Johnson and Johnson   (France)

ⁱ CARDIALYSIS   (Netherlands)

^j INSTITUT CARDIOVASCULAIRE PARIS SUD   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; DISEASE-FREE SURVIVAL; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEPARIN; HUMANS; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; RECURRENCE; STENTS;

EID: 0033599063     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199912233412601     Document Type: Article

References (29)

1. Grines CL. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty - the strategy of choice. N Engl J Med 1996;335:1313-7.
2. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9.
3. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4.
4. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8. [Erratum, JAMA 1998;279:1876.]
5. Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1997;29:1459-67.
6. Brodie BR, Grines CL, Ivanhoe R, et al. Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction: final results from the Primary Angioplasty Registry. Circulation 1994;90:156-62.
7. O'Neill WW, Weintraub R, Grines CL, et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation 1992;86:1710-7.
8. Grines C, Brodie B, Griffin J, et al. Which primary PTCA patients may benefit from new technologies? Circulation 1995;92:Suppl I:1-146. abstract.
9. Monassier JP, Elias J, Meyer P, Morice MC, Royer T, Cribler A. STENTIM I: the French Registry of stenting at acute myocardial infarction. J Am Coll Cardiol 1996;27:Suppl A:68A. abstract.
10. Hardhammar PA, van Beusekom HMM, Emanuelsson HU, et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996;93:423-30.
11. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparin-coated Palmaz-Schatz stents in human coronary arteries: early outcome of the Benestent-II Pilot Study. Circulation 1996;93:412-22.
12. Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease. Lancet 1998;352:673-81 [Erratum, Lancet 1998;352:1478].
13. Serruys PW, Grines CL, Stone GW, et al. Stent implantation in acute myocardial infarction using a heparin-coated stent: a pilot study as a preamble to a randomized trial comparing balloon angioplasty and stenting. Int J Cardiovasc Interventions 1998;1:19-27.
14. Grines CL. Contrast media: is there a preferable agent for coronary interventions? J Am Coll Cardiol 1997;29:1122-3.
15. Grines CL, Stone GW, O'Neill WW. Establishing a program and performance of primary PTCA - the PAMI way. J Interventional Cardiol 1997;9:Suppl B:44B-52B.
16. Gronenschild E, Janssen J, Tijdens F. CAAS. II. A second generation system for off-line and on-line quantitative coronary angiography. Cathet Cardiovasc Diagn 1994;33:61-75.
17. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation 1990;82:1193-202.
18. Lansky AJ, Popma JJ. Qualitative and quantitative angiography. In: Topol EJ, ed. Textbook of interventional cardiology. 3rd ed. Philadelphia: W.B. Saunders, 1999:725-47.
19. The TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985;312:932-6.
20. Suryapranata H, van't Hof AWJ, Hoorntje JCA, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97: 2502-5.
21. Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Fazzini PF. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. J Am Coll Cardiol 1998;31:1234-9.
22. Rodriguez A, Bernardi V, Fernandez M, et al. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am J Cardiol 1998;81:1286-91.
23. Tommaso CL, Bergelson BA. Diminishing impact of in-lab complications. Cathet Cardiovasc Diagn 1997;42:257-8.
24. Stone GW, Brodie BR, Griffin JJ, et al. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. J Am Coll Cardiol 1998;31:23-30.
25. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
26. The IMPACT-II Investigators. Randomised placebo-controlled trial of effect of eptifibatide on complications of percutaneous coronary intervention: IMPACT-II. Lancet 1997;349:1422-8.
27. Topol EJ, Califf RM, Vandormael M, et al. A randomized trial of late reperfusion therapy for acute myocardial infarction. Circulation 1992;85: 2090-9.
28. Meijer A, Verheugt FWA, Werter CJPJ, Lie KI, van der Pol JMJ, van Eenige MJ. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study: results of the APRICOT Study. Circulation 1993;87:1524-30.
29. White HD, French JK, Hamer AW, et al. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of anti-platelet therapy. J Am Coll Cardiol 1995;25:218-23.